Name of the cohort: GINIplus

Official homepage of the study. 

Further information on the website of the Helmholtz Association Munich.

Basic characteristics of the study: GINIplus is a multicentre, population-based prospective birth cohort study. The study consists of two arms: an interventional and an observational arm. Both arms together represent a population-based birth cohort. Newborns with family history of allergy were recruited for the interventional arm (GINI = German Infant Nutritional Intervention program): a randomized, double-blind controlled trial with 3 hydrolysed formula versus cow’s milk formula feeding during first 4 months of life (n=1165 in Munich, n=1087 in Wesel). Newborns with a negative family history or positive family history but refusing participation at the trial were included to the observational study arm.
For the ongoing 15-year-follow up more than 3300 children will be followed.

Category of the cohort: Mature birth cohort.

Kind of biomaterials available in the cohorts, i.e. data collected in the cohorts: Biomarkers and genetic data.

Application process to access the biomaterials: an application needs to be sent to the GINIplus Principal Investigators.

Cohorts’ data, which can be already used within iMed: Extensive data on risk factors, diseases, genetics and biomarkers can be already applied.

Contact person for the cohort: Dr. Joachim Heinrich (heinrich(at), Helmholtz Zentrum München, Institute of Epidemiology I.

to top